10th SYMPOSIUM OF VACCINOLOGY - March 20-21,2017 - Palais Hirsch, Université Lumière Lyon II
upload_fichiers/1480667060-programme-sfi-vaccino-2017.pdf
Monday, March 20
1 0 t h SYMPOSIUM OF VACCINOLOGY
10:15 - WELCOME ADRESSES
B. Dubois, Lyon - France - Cancer Research Center
A. Mérieux, Lyon - France - Institut & Fondation Mérieux
10:30 - OPENING LECTURE
Y. J. Liu, Sano , Cambridge - USA - Cancer Immunotherapy : six principles for combination therapy.
11:15 - SESSION I: BASIC IMMUNOLOGY/VACCINOLOGY
E. Vivier, Centre d'Immunologie de Marseille Luminy - France - Innate lymphoid cells, new actors of immunity
F. L. Cosset, CIRI, Lyon - France - New technologies for achieving e cient gene delivery to immune cells
N. Cerf-Bensussan, Institut Imagine, Université Paris Descartes, Paris - France - Impact of the microbiote on local and
systemic immune responses in mice
B. Levaste, Maat-Pharma, Lyon - France - Short talk #1 - Title to be announced
13:00 - LUNCH & POSTER VISIT
14:30 - SESSION II: ANIMAL MODELS
R. Legrand, IMETI, Fontenay-Aux-Roses -France - The use of non-human primate models to dissect innate and acquired
immune responses to MVA vectored vaccines
A. Osterhaus, University of Rotterdam - Netherlands - Vaccination from a One Health perspective : cross-species
approaches
S. Paul, GIMAP, INSERM, Saint Etienne - France - Use of sIgA as mucosal vaccine vehicle
Short talk #2
16:15 - COFFEE BREAK
16:45 - SESSION III: Development of Vaccines in an Emergency Situation
M. P. Kieny, WHO, Geneva -Switzerland - Development of vaccines during the EBOLA public health emergency :
lessons learnt
C. A. Siegrist, Geneva University - Switzerland - Safety signatures of the rVSV-ZEBOV candidate vaccine
Short talk #3
Short talk #4
18:15 COCKTAIL & POSTER VISIT
08:30 - SESSION IV: Vaccines in Development
C. Locht, Institut Pasteur, Lille - France - On- and o -target e ects of a live attenuated pertussis vaccine : from
concepts to clinical development
G. Glenn, Novavax, Gaithersburg - USA - Advances towards a vaccine for RSV : insights from clinical trials and direction
forward
L. Quémeneur, Sano pasteur, Marcy L'Etoile - France - Preclinical studies of a toxoid vaccine candidate for the
prevention of Clostridium di cile infection
Short talk #5
Short talk #6
10:30 - COFFEE BREAK
11:00 - F. Tangy, Institut Pasteur de Paris - France - Development of live measles vaccine vector for new pathogens
B. Charleston, Pirbright Institute - UK - Foot-and-mouth disease vaccine developed using structural vaccinology
P. Poignard, Institut de Biologie Structurale, Grenoble - France - Broadly neutralizing antibodies o er new prospects to
counter HIV
Short talk #7
Short talk #8
13:00 - Lunch and Poster visit
14:00 - SESSION V: Cancer Vaccines and Immunotherapy
D. Speiser, Ludwig Cancer Research Center, Lausanne - Switzerland - Regulation of T cell function in cancer
E. Quémeneur, Transgene, Strasbourg - France - Engineering of oncolytic viruses to boost their immunological
properties
S. H. Van Der Burg, Leiden University Medical Center - Netherlands - Therapeutic vaccines for treatment of HPV-driven
cancers
C. Leclerc, Institut Pasteur de Paris - France - A Phase I study of the MAG-Tn3 therapeutic vaccine candidate in
patients with breat cancer at high risk of relapse
Short talk #9
Short talk #10
16:15 - Closing Lecture
M. Saville, Crucell, Janssen Pharmaceuticals - Netherlands - Title to be announced
17:00 - Concluding remarks and end of the meeting
upload_fichiers/1480667060-programme-sfi-vaccino-2017.pdf
Monday, March 20
1 0 t h SYMPOSIUM OF VACCINOLOGY
10:15 - WELCOME ADRESSES
B. Dubois, Lyon - France - Cancer Research Center
A. Mérieux, Lyon - France - Institut & Fondation Mérieux
10:30 - OPENING LECTURE
Y. J. Liu, Sano , Cambridge - USA - Cancer Immunotherapy : six principles for combination therapy.
11:15 - SESSION I: BASIC IMMUNOLOGY/VACCINOLOGY
E. Vivier, Centre d'Immunologie de Marseille Luminy - France - Innate lymphoid cells, new actors of immunity
F. L. Cosset, CIRI, Lyon - France - New technologies for achieving e cient gene delivery to immune cells
N. Cerf-Bensussan, Institut Imagine, Université Paris Descartes, Paris - France - Impact of the microbiote on local and
systemic immune responses in mice
B. Levaste, Maat-Pharma, Lyon - France - Short talk #1 - Title to be announced
13:00 - LUNCH & POSTER VISIT
14:30 - SESSION II: ANIMAL MODELS
R. Legrand, IMETI, Fontenay-Aux-Roses -France - The use of non-human primate models to dissect innate and acquired
immune responses to MVA vectored vaccines
A. Osterhaus, University of Rotterdam - Netherlands - Vaccination from a One Health perspective : cross-species
approaches
S. Paul, GIMAP, INSERM, Saint Etienne - France - Use of sIgA as mucosal vaccine vehicle
Short talk #2
16:15 - COFFEE BREAK
16:45 - SESSION III: Development of Vaccines in an Emergency Situation
M. P. Kieny, WHO, Geneva -Switzerland - Development of vaccines during the EBOLA public health emergency :
lessons learnt
C. A. Siegrist, Geneva University - Switzerland - Safety signatures of the rVSV-ZEBOV candidate vaccine
Short talk #3
Short talk #4
18:15 COCKTAIL & POSTER VISIT
08:30 - SESSION IV: Vaccines in Development
C. Locht, Institut Pasteur, Lille - France - On- and o -target e ects of a live attenuated pertussis vaccine : from
concepts to clinical development
G. Glenn, Novavax, Gaithersburg - USA - Advances towards a vaccine for RSV : insights from clinical trials and direction
forward
L. Quémeneur, Sano pasteur, Marcy L'Etoile - France - Preclinical studies of a toxoid vaccine candidate for the
prevention of Clostridium di cile infection
Short talk #5
Short talk #6
10:30 - COFFEE BREAK
11:00 - F. Tangy, Institut Pasteur de Paris - France - Development of live measles vaccine vector for new pathogens
B. Charleston, Pirbright Institute - UK - Foot-and-mouth disease vaccine developed using structural vaccinology
P. Poignard, Institut de Biologie Structurale, Grenoble - France - Broadly neutralizing antibodies o er new prospects to
counter HIV
Short talk #7
Short talk #8
13:00 - Lunch and Poster visit
14:00 - SESSION V: Cancer Vaccines and Immunotherapy
D. Speiser, Ludwig Cancer Research Center, Lausanne - Switzerland - Regulation of T cell function in cancer
E. Quémeneur, Transgene, Strasbourg - France - Engineering of oncolytic viruses to boost their immunological
properties
S. H. Van Der Burg, Leiden University Medical Center - Netherlands - Therapeutic vaccines for treatment of HPV-driven
cancers
C. Leclerc, Institut Pasteur de Paris - France - A Phase I study of the MAG-Tn3 therapeutic vaccine candidate in
patients with breat cancer at high risk of relapse
Short talk #9
Short talk #10
16:15 - Closing Lecture
M. Saville, Crucell, Janssen Pharmaceuticals - Netherlands - Title to be announced
17:00 - Concluding remarks and end of the meeting